FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Bates

Research Profile

Chemicals & Drugs

Physiology

Anatomy

Disorders

Co-author Network

Publications

TOP 3
Agnes Basseville; Ramanujan S Hegde; Caterina Ierano; Robert W Robey; Akina Tamaki; Shana Trostel; Yvona Ward; Susan E Bates
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.
Robin Frye; Mary Myers; Elizabeth A Ness; Richard L Piekarz; Karen C Axelrod; Susan E Bates; Susan Booher
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma.
Laleh Amiri-Kordestani; Agnes Basseville; Antonio Tito Fojo; Karen Kurdziel; Susan E Bates
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Bates (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Agnes Basseville; Ramanujan S Hegde; Caterina Ierano; Robert W Robey; Akina Tamaki; Shana Trostel; Yvona Ward; Susan E Bates
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.
Cancer research 2012;72(14):3642-51.
2012: Robin Frye; Mary Myers; Elizabeth A Ness; Richard L Piekarz; Karen C Axelrod; Susan E Bates; Susan Booher
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma.
Clinical journal of oncology nursing 2012;16(2):195-204.
2012: Laleh Amiri-Kordestani; Agnes Basseville; Antonio Tito Fojo; Karen Kurdziel; Susan E Bates
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2012;15(1-2):50-61.
2012: Brian C Shaffer; Chirayu Patel; Maria R Baer; Susan E Bates; Jean-Pierre Gillet; Michael M Gottesman
Drug resistance: still a daunting challenge to the successful treatment of AML.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2012;15(1-2):62-9.
2012: Tristan M Sissung; Hyeyoung Sung; Sarah M Troutman; Susan E Bates; Tessa J Campbell; Heather M Pressler; William D Figg
Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.
Discovery medicine 2012;13(68):19-34.
2011: Tito Fojo; Laleh Amiri-Kordestani; Susan E Bates
Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer.
Journal of the National Cancer Institute 2011;103(23):1738-40.
2011: Robert W Robey; Zhirong Zhan; Julian Bahr; Agnes Basseville; Arup R Chakraborty; Victoria Luchenko; Susan E Bates
Histone deacetylase inhibitors: emerging mechanisms of resistance.
Molecular pharmaceutics 2011;8(6):2021-31.
2011: Victoria L Luchenko; Robert F Murphy; Yves Pommier; Crystal D Salcido; Keli Agama; Susan E Bates; Giuseppe Giaccone; Edina Komlodi-Pasztor; Yongwei Zhang; Lyuba Varticovski
Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer.
Cell cycle (Georgetown, Tex.) 2011;10(18):3119-28.
2011: Akina Tamaki; Caterina Ierano; Robert W Robey; Gergely Szakacs; Susan E Bates
The controversial role of ABC transporters in clinical oncology.
Essays in biochemistry 2011;50(1):209-32.
2011: Richard L Piekarz; Robin Frye; H Miles Prince; Mark H Kirschbaum; Jasmine Zain; Steven Allen; Elaine S Jaffe; Alexander Ling; Maria Turner; Cody J Peer; William D Figg; Seth M Steinberg; Sonali Smith; David Joske; Ian Lewis; Laura Hutchins; Michael Craig; Antonio Tito Fojo; John J Wright; Susan E Bates
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
Blood 2011;117(22):5827-34.
2011: Robert W Robey; Bo Lin; Jean Qiu; Leo Li-Ying Chan; Susan E Bates
Rapid detection of ABC transporter interaction: potential utility in pharmacology.
Journal of pharmacological and toxicological methods 2011;63(3):217-22.
2011: Kenneth K W To; Robert W Robey; Zhirong Zhan; Lois Bangiolo; Susan E Bates
Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway.
Molecular cancer research : MCR 2011;9(4):516-27.
2011: Muhammad Ali Versiani; Thushara Diyabalanage; Ranjala Ratnayake; Curtis J Henrich; Susan E Bates; James B McMahon; Kirk R Gustafson
Flavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2.
Journal of natural products 2011;74(2):262-6.
2011: Tristan Sissung; Erin R Gardner; Richard L Piekarz; Reuben Howden; Xiaohong Chen; Sukyung Woo; Ryan Franke; James A Clark; Laura Miller-DeGraff; Seth M Steinberg; David Venzon; David J Liewehr; Steven R Kleeberger; Susan E Bates; Douglas K Price; Douglas R Rosing; Christopher Cabell; Alex Sparreboom; William D Figg
Impact of ABCB1 allelic variants on QTc interval prolongation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(4):937-46.
2011: Ronan J Kelly; Deborah Draper; Clara C Chen; Robert W Robey; William D Figg; Richard L Piekarz; Xiaohong Chen; Erin R Gardner; FRANK BALIS; Aradhana Venkatesan; Seth M Steinberg; Tito Fojo; Susan E Bates
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(3):569-80.
2011: Agnès Basseville; Susan E Bates
Gout, genetics and ABC transporters.
F1000 biology reports 2011;3():23.
2010: Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(23):5608-17.
2010: Nicola F Smith; Sridhar Mani; Erin G Schuetz; Kazuto Yasuda; Tristan M Sissung; Susan E Bates; William D Figg; Alex Sparreboom
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2.
The Annals of pharmacotherapy 2010;44(11):1709-17.
2010: Robert W Robey; Paul R Massey; Laleh Amiri-Kordestani; Susan E Bates
ABC transporters: unvalidated therapeutic targets in cancer and the CNS.
Anti-cancer agents in medicinal chemistry 2010;10(8):625-33.
2010: Marius Dohse; Christian Scharenberg; Suneet Shukla; Robert W Robey; Thorsten Volkmann; John F Deeken; Cornelia Brendel; Suresh V Ambudkar; Andreas Neubauer; Susan E Bates
Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.
Drug metabolism and disposition: the biological fate of chemicals 2010;38(8):1371-80.
2010: Christina M Annunziata; Susan E Bates
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer.
F1000 biology reports 2010;2():.
2010: Susan E Bates; Zhirong Zhan; Kenneth Steadman; Tomasz Obrzut; Victoria Luchenko; Robin Frye; Robert W Robey; Maria Turner; Erin R Gardner; William D Figg; Seth M Steinberg; Alex Ling; Tito Fojo; Kin Wah To; Richard L Piekarz
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.
British journal of haematology 2010;148(2):256-67.
2009: Richard L Piekarz; Robin Frye; Maria Turner; John J Wright; Steven Allen; Mark H Kirschbaum; Jasmine Zain; H Miles Prince; John P Leonard; Larisa J Geskin; Craig Reeder; David Joske; William D Figg; Erin R Gardner; Seth M Steinberg; Elaine S Jaffe; Maryalice Stetler-Stevenson; Stephen Lade; A Tito Fojo; Susan E Bates
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5410-7.
2009: John F Deeken; Robert W Robey; Suneet Shukla; Kenneth Steadman; Arup R Chakraborty; Balasubramanian Poonkuzhali; Erin G Schuetz; Susan Holbeck; Suresh V Ambudkar; Susan E Bates
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
Molecular pharmacology 2009;76(5):946-56.
2009: David Ritchie; Richard L Piekarz; Piers Blombery; Laszlo J Karai; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld; John E Janik; H Miles Prince; Susan E Bates
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.
Haematologica 2009;94(11):1618-22.
2009: Kenneth K W To; Robert W Robey; Turid Knutsen; Zhirong Zhan; Thomas Ried; Susan E Bates
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.
Molecular cancer therapeutics 2009;8(10):2959-68.
2009: Wilfred D Stein; Hui Huang; Michael Menefee; Maureen Edgerly; Herb Kotz; Andrew Dwyer; James Yang; Susan E Bates
Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma.
Cancer journal (Sudbury, Mass.) 2009;15(5):441-7.
2009: Tatiana Vidaurre; Julia Wilkerson; Richard Simon; Susan E Bates; Tito Fojo
Stable disease is not preferentially observed with targeted therapies and as currently defined has limited value in drug development.
Cancer journal (Sudbury, Mass.) 2009;15(5):366-73.
2009: Robert W Robey; Tomasz Obrzut; Suneet Shukla; Orsolya Polgar; Sira Macalou; Julian C Bahr; Attilio Di Pietro; Suresh V Ambudkar; Susan E Bates
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
Cancer chemotherapy and pharmacology 2009;64(3):575-83.
2009: Orsolya Polgar; Lilangi S Ediriwickrema; Robert W Robey; Ajay Sharma; Ramanujan S Hegde; Yongfu Li; Di Xia; Yvona Ward; Michael Dean; Csilla Ozvegy-Laczka; Balázs Sarkadi; Susan E Bates
Arginine 383 is a crucial residue in ABCG2 biogenesis.
Biochimica et biophysica acta 2009;1788(7):1434-43.
2009: Richard L Piekarz; Susan E Bates
Epigenetic modifiers: basic understanding and clinical development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):3918-26.
2009: Susan E Bates; Edward J Benz
Commentary: troublesome words, linguistic precision, and medical oncology.
The oncologist 2009;14(4):445-7.
2009: Sukyung Woo; Erin R Gardner; Xiaohong Chen; Sandra B Ockers; Caitlin E Baum; Tristan Sissung; Douglas K Price; Robin Frye; Richard L Piekarz; Susan E Bates; William D Figg
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1496-503.
2009: Orsolya Polgar; John F Deeken; Lilangi S Ediriwickrema; Akina Tamaki; Seth M Steinberg; Robert W Robey; Susan E Bates
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.
Molecular and cellular biochemistry 2009;322(1-2):63-71.
2009: Suneet Shukla; Robert W Robey; Susan E Bates; Suresh V Ambudkar
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
Drug metabolism and disposition: the biological fate of chemicals 2009;37(2):359-65.
2009: Robert W Robey; Kenneth K K To; Orsolya Polgar; Marius Dohse; Patricia A Fetsch; Michael Dean; Susan E Bates
ABCG2: a perspective.
Advanced drug delivery reviews 2009;61(1):3-13.
2008: Kenneth K W To; Zhirong Zhan; Thomas Litman; Susan E Bates
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
Molecular and cellular biology 2008;28(17):5147-61.
2008: Deirdre O'Mahony; Richard L Peikarz; W Patricia Bandettini; Andrew Arai; Wyndham H Wilson; Susan E Bates
Cardiac involvement with lymphoma: a review of the literature.
Clinical lymphoma & myeloma 2008;8(4):249-52.
2008: Anna Maria Calcagno; Jennifer Fostel; K K W To; C D Salcido; S E Martin; K J Chewning; Chung-Pu Wu; Lyuba Varticovski; Susan E Bates; Natasha J Caplen; Suresh V Ambudkar
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes.
British journal of cancer 2008;98(9):1515-24.
2008: Robert W Robey; Alberto Lazarowski; Susan E Bates
P-glycoprotein--a clinical target in drug-refractory epilepsy?
Molecular pharmacology 2008;73(5):1343-6.
2008: Robert W Robey; Suneet Shukla; Elizabeth M Finley; Robert K Oldham; Daryl Barnett; Suresh V Ambudkar; Tito Fojo; Susan E Bates
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
Biochemical pharmacology 2008;75(6):1302-12.
2008: Zhiyong Liao; Robert W Robey; Josée Guirouilh-Barbat; Kenneth K W To; Orsolya Polgar; Susan E Bates; Yves Pommier
Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan.
Molecular pharmacology 2008;73(2):490-7.
2008: Kenneth K W To; Orsolya Polgar; Lyn Mickley Huff; Kuniaki Morisaki; Susan E Bates
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
Molecular cancer research : MCR 2008;6(1):151-64.
2007: Sen H Zhuang; Y Elizabeth Hung; Laura Hung; Robert W Robey; Dan L Sackett; W Marston Linehan; Susan E Bates; Tito Fojo; Marianne S Poruchynsky
Evidence for microtubule target engagement in tumors of patients receiving ixabepilone.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7480-6.
2007: Kazutaka Takagi; Thomas S Dexheimer; Christophe Redon; Olivier Sordet; Keli Agama; Gilbert Lavielle; Alain Pierré; Susan E Bates; Yves Pommier
Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters.
Molecular cancer therapeutics 2007;6(12 Pt 1):3229-38.
2007: Wanqing Liu; Xiaolin Wu; Wei Zhang; Raquel C Montenegro; Donna Lee Fackenthal; Jared A Spitz; Lyn Mickley Huff; Federico Innocenti; Soma Das; Edwin H Cook; Nancy J Cox; Susan E Bates; Mark J Ratain
Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6788-95.
2007: Robert W Robey; Suneet Shukla; Kenneth Steadman; Tomasz Obrzut; Elizabeth M Finley; Suresh V Ambudkar; Susan E Bates
Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure.
Molecular cancer therapeutics 2007;6(6):1877-85.
2007: Elizabeth Fox; Susan E Bates
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
Expert review of anticancer therapy 2007;7(4):447-59.
2007: William G Telford; Jolene Bradford; William Godfrey; Robert W Robey; Susan E Bates
Side population analysis using a violet-excited cell-permeable DNA binding dye.
Stem cells (Dayton, Ohio) 2007;25(4):1029-36.
2007: Susan E Bates; Richard L Piekarz
Histone deacetylase inhibitors in combinations: will the preclinical promises be kept?
Cancer journal (Sudbury, Mass.) 2007;13(2):80-3.
2007: Robert W Robey; Orsolya Polgar; John Deeken; Kin Wah To; Susan E Bates
ABCG2: determining its relevance in clinical drug resistance.
Cancer metastasis reviews 2007;26(1):39-57.
2007: Yong-Fu Li; Orsolya Polgar; Masaki Okada; Lothar Esser; Susan E Bates; Di Xia
Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study.
Journal of molecular graphics & modelling 2007;25(6):837-51.
2007: Merrill E Goldsmith; Alian Aguila; Kenneth Steadman; Alfredo Martinez; Seth M Steinberg; Michael C Alley; William R Waud; Susan E Bates; Tito Fojo
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems.
Molecular cancer therapeutics 2007;6(2):496-505.
2007: John F Deeken; William D Figg; Susan E Bates; Alex Sparreboom
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Anti-cancer drugs 2007;18(2):111-26.
2007: Richard L Piekarz; Dan L Sackett; Susan E Bates
Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy.
Cancer journal (Sudbury, Mass.) 2007;13(1):30-9.
2006: Robert W Robey; Patricia A Fetsch; Orsolya Polgar; Michael Dean; Susan E Bates
The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2.
Research in veterinary science 2006;81(3):345-9.
2006: Kenneth K W To; Z Zhan; Susan E Bates
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
Molecular and cellular biology 2006;26(22):8572-85.
2006: Maria V Nesterova; Natalie Johnson; Chris Cheadle; Susan E Bates; Sridhar Mani; Constantine Straturis; Islam U Khan; Islam Kahn; Rishab K Gupta; Yoon S Cho-Chung
Autoantibody cancer biomarker: extracellular protein kinase A.
Cancer research 2006;66(18):8971-4.
2006: Suneet Shukla; Robert W Robey; Susan E Bates; Suresh V Ambudkar
The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
Biochemistry 2006;45(29):8940-51.
2006: Susan E Bates; Douglas R Rosing; Tito Fojo; Richard L Piekarz
Challenges of evaluating the cardiac effects of anticancer agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3871-4.
2006: Richard L Piekarz; A Robin Frye; John J Wright; Seth M Steinberg; David J Liewehr; Douglas R Rosing; Vandana Sachdev; Tito Fojo; Susan E Bates
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3762-73.
2006: Orsolya Polgar; Csilla Ozvegy-Laczka; Robert W Robey; Kuniaki Morisaki; Masaki Okada; Akina Tamaki; Gabriella Koblos; N Barry Elkind; Yvona Ward; Michael Dean; Balázs Sarkadi; Susan E Bates
Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.
Biochemistry 2006;45(16):5251-60.
2006: Patricia A Fetsch; Andrea Abati; Thomas Litman; Kuniaki Morisaki; Yasumasa Honjo; Khush Mittal; Susan E Bates
Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.
Cancer letters 2006;235(1):84-92.
2006: Robert W Robey; Zhirong Zhan; Richard L Piekarz; Ganesh L Kayastha; Tito Fojo; Susan E Bates
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1547-55.
2005: Kuniaki Morisaki; Robert W Robey; Csilla Ozvegy-Laczka; Yasumasa Honjo; Orsolya Polgar; Kenneth Steadman; Balázs Sarkadi; Susan E Bates
Single nucleotide polymorphisms modify the transporter activity of ABCG2.
Cancer chemotherapy and pharmacology 2005;56(2):161-72.
2005: V Koneti Rao; Danny Wangsa; Robert W Robey; Lyn Mickley Huff; Yasumasa Honjo; Jeffrey Hung; Turid Knutsen; Thomas Ried; Susan E Bates
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells.
Cancer genetics and cytogenetics 2005;160(2):126-33.
2005: Robert W Robey; Kenneth Steadman; Orsolya Polgar; Susan E Bates
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Cancer biology & therapy 2005;4(2):187-94.
2005: Orsolya Polgar; Susan E Bates
ABC transporters in the balance: is there a role in multidrug resistance?
Biochemical Society transactions 2005;33(Pt 1):241-5.
2005: Yukitaka Shizukuda; Richard L Piekarz; Susan E Bates; Vandana Sachdev; TOREN FINKEL; Douglas R Rosing
Effect of a histone deacetylase inhibitor on human cardiac mass.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(1):89-90.
2004: Kyunghwa Hwang; Richard L Piekarz; Susan E Bates; William D Figg; Alex Sparreboom
Determination of the cyclic depsipeptide FK228, a histone deacetylase inhibitor, by liquid chromatography-mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;809(1):81-6.
2004: Susan E Bates; Wilma Y Medina-Pérez; Glenda Kohlhagen; Smitha Antony; Tim Nadjem; Robert W Robey; Yves Pommier
ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins.
The Journal of pharmacology and experimental therapeutics 2004;310(2):836-42.
2004: Orsolya Polgar; Robert W Robey; Kuniaki Morisaki; Michael Dean; Christopher Michejda; Zuben Sauna; Suresh V Ambudkar; Nadya Tarasova; Susan E Bates
Mutational analysis of ABCG2: role of the GXXXG motif.
Biochemistry 2004;43(29):9448-56.
2004: Susan E Bates; Susan Bakke; Min Kang; Robert W Robey; Suoping Zhai; Paul Thambi; Clara C Chen; Sheela Patil; Tom Smith; Seth M Steinberg; Maria Merino; Barry Goldspiel; Beverly Meadows; Wilfred D Stein; Peter Choyke; FRANK BALIS; William D Figg; Tito Fojo
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4724-33.
2004: Susan D Mertins; Timothy G Myers; Susan Holbeck; Wilma Medina-Perez; Elaine Wang; Glenda Kohlhagen; Yves Pommier; Susan E Bates
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
Molecular cancer therapeutics 2004;3(7):849-60.
2004: Richard L Piekarz; Robert W Robey; Zhirong Zhan; Ganesh L Kayastha; Anousheh Sayah; Amina H Abdeldaim; Sonia Torrico; Susan E Bates
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance.
Blood 2004;103(12):4636-43.
2004: Robert W Robey; Kenneth Steadman; Orsolya Polgar; Kuniaki Morisaki; Margaret Blayney; Prakash Mistry; Susan E Bates
Pheophorbide a is a specific probe for ABCG2 function and inhibition.
Cancer research 2004;64(4):1242-6.
2003: Robert W Robey; Yasumasa Honjo; Kuniaki Morisaki; T A Nadjem; S Runge; M Risbood; Marianne S Poruchynsky; Susan E Bates
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.
British journal of cancer 2003;89(10):1971-8.
2003: Gregory D Leonard; Tito Fojo; Susan E Bates
The role of ABC transporters in clinical practice.
The oncologist 2003;8(5):411-24.
2002: Yasumasa Honjo; Kuniaki Morisaki; Lyn Mickley Huff; Robert W Robey; Jeffrey Hung; Michael Dean; Susan E Bates
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).
Cancer biology & therapy 2002;1(6):696-702.
2002: Gregory D Leonard; Orsolya Polgar; Susan E Bates
ABC transporters and inhibitors: new targets, new agents.
Current opinion in investigational drugs (London, England : 2000) 2002;3(11):1652-9.
2002: Jerry Jaboin; Jason Wild; Habib Hamidi; Chand Khanna; Chong Jai Kim; Robert W Robey; Susan E Bates; Carol Jeanne Thiele
MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.
Cancer research 2002;62(21):6108-15.
2002: Victor A Sandor; Susan Bakke; Robert W Robey; Min H Kang; Mikhail V Blagosklonny; Jonathon Bender; Rebecca Brooks; Richard L Piekarz; Eben Tucker; William D Figg; Kenneth K Chan; Barry Goldspiel; Antonio Tito Fojo; Stanley P Balcerzak; Susan E Bates
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):718-28.
2002: Philippe C Bishop; Timothy Myers; Robert W Robey; David W Fry; Edison Liu; Mikhail V Blagosklonny; Susan E Bates
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.
Oncogene 2002;21(1):119-27.
2002: Michael M Gottesman; Tito Fojo; Susan E Bates
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nature reviews. Cancer 2002;2(1):48-58.
2001: Susan E Bates; Robert W Robey; K Miyake; K Rao; Douglas Ross; Thomas Litman
The role of half-transporters in multidrug resistance.
Journal of bioenergetics and biomembranes 2001;33(6):503-11.
2001: Richard L Piekarz; Robert W Robey; Victor A Sandor; Susan Bakke; Wyndham H Wilson; L Dahmoush; D M Kingma; Maria L Turner; Rosemary M Altemus; Susan E Bates
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.
Blood 2001;98(9):2865-8.
2001: Yasumasa Honjo; CA Hrycyna; Q W Yan; Wilma Y Medina-Pérez; Robert W Robey; A van de Laar; Thomas Litman; Michael Dean; Susan E Bates
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.
Cancer research 2001;61(18):6635-9.
2001: Robert W Robey; Yasumasa Honjo; A van de Laar; K Miyake; JT Regis; Thomas Litman; Susan E Bates
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).
Biochimica et biophysica acta 2001;1512(2):171-82.
2001: M H Kang; William D Figg; Yuichi Ando; Mikhail V Blagosklonny; David J Liewehr; Tito Fojo; Susan E Bates
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1610-7.
2001: Susan D Mertins; Timothy G Myers; Melinda G Hollingshead; D Dykes; E Bodde; P Tsai; C A Jefferis; R Gupta; W Marston Linehan; Michael C Alley; Susan E Bates
Screening for and identification of novel agents directed at renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):620-33.
2001: Robert W Robey; Wilma Y Medina-Pérez; K Nishiyama; Tyler Lahusen; K Miyake; Thomas Litman; Adrian M Senderowicz; Douglas Ross; Susan E Bates
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):145-52.
2000: Victor A Sandor; Adrian M Senderowicz; Susan D Mertins; Dan L Sackett; Edward A Sausville; Mikhail V Blagosklonny; Susan E Bates
P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228.
British journal of cancer 2000;83(6):817-25.
2000: K Wosikowski; J A Silverman; P Bishop; J Mendelsohn; Susan E Bates
Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells.
Biochimica et biophysica acta 2000;1497(2):215-26.
2000: Victor A Sandor; A R Robbins; Robert W Robey; T Myers; Edward A Sausville; Susan E Bates; Dan L Sackett
FR901228 causes mitotic arrest but does not alter microtubule polymerization.
Anti-cancer drugs 2000;11(6):445-54.
2000: Mikhail V Blagosklonny; Philippe C Bishop; Robert W Robey; Tito Fojo; Susan E Bates
Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.
Cancer research 2000;60(13):3425-8.
2000: Thomas Litman; M Brangi; E Hudson; Patricia A Fetsch; Andrea Abati; Douglas Ross; K Miyake; James Resau; Susan E Bates
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2).
Journal of cell science 2000;113 ( Pt 11)():2011-21.
1999: M Brangi; Thomas Litman; Marco Ciotti; K Nishiyama; Glenda Kohlhagen; Chris H Takimoto; Robert W Robey; Yves Pommier; Tito Fojo; Susan E Bates
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.
Cancer research 1999;59(23):5938-46.
1999: M de Bruin; K Miyake; Thomas Litman; Robert W Robey; Susan E Bates
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.
Cancer letters 1999;146(2):117-26.
1999: E Gamelin; Susan D Mertins; JT Regis; Lyn A Mickley; Andrea Abati; Robert Worrell; W Marston Linehan; Susan E Bates
Intrinsic drug resistance in primary and metastatic renal cell carcinoma.
The Journal of urology 1999;162(1):217-24.
1999: Susan E Bates; Zhirong Zhan; J Regis; E Gamelin
Measuring MDR-1 by Quantitative RT-PCR.
Methods in molecular medicine 1999;28():63-81.
1999: K Miyake; Lyn A Mickley; Thomas Litman; Zhirong Zhan; Robert W Robey; B Cristensen; M Brangi; Lee M Greenberger; Michael Dean; Tito Fojo; Susan E Bates
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
Cancer research 1999;59(1):8-13.
1998: Lyn A Mickley; Jong-Seok Lee; Z Weng; Zhirong Zhan; M Alvarez; W Wilson; Susan E Bates; Tito Fojo
Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.
Blood 1998;91(5):1749-56.
1998: Victor A Sandor; Tito Fojo; Susan E Bates
Future perspectives for the development of P-glycoprotein modulators.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 1998;1(3):190-200.
1997: K Wosikowski; D Schuurhuis; G J Kops; M Saceda; Susan E Bates
Altered gene expression in drug-resistant human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2405-14.
1997: Victor A Sandor; W Wilson; Tito Fojo; Susan E Bates
The role of MDR-1 in refractory lymphoma.
Leukemia & lymphoma 1997;28(1-2):23-31.
1997: K Wosikowski; D Schuurhuis; K Johnson; KD Paull; Timothy G Myers; John N Weinstein; Susan E Bates
Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Journal of the National Cancer Institute 1997;89(20):1505-15.
1997: J S Lee; S Scala; Y Matsumoto; B Dickstein; Robert W Robey; Zhirong Zhan; G Altenberg; Susan E Bates
Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
Journal of cellular biochemistry 1997;65(4):513-26.
1997: S Scala; N Akhmed; U S Rao; KD Paull; L B Lan; B Dickstein; J S Lee; G H Elgemeie; Wilfred D Stein; Susan E Bates
P-glycoprotein substrates and antagonists cluster into two distinct groups.
Molecular pharmacology 1997;51(6):1024-33.
1997: Zhirong Zhan; Victor A Sandor; E Gamelin; JT Regis; B Dickstein; W Wilson; Antonio Tito Fojo; Susan E Bates
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
Blood 1997;89(10):3795-800.
1997: Clara C Chen; Beverly Meadows; JT Regis; G Kalafsky; Tito Fojo; Jorge Carrasquillo; Susan E Bates
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):545-52.
1996: S Scala; K Wosikowski; Paraskevi Giannakakou; P Valle; J L Biedler; B A Spengler; Enrico Lucarelli; Susan E Bates; Carol Jeanne Thiele
Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
Cancer research 1996;56(16):3737-42.
1996: William T Beck; Thomas M Grogan; Cheryl L Willman; C Cordon-Cardo; David M Parham; John Frank Kuttesch; M Andreeff; Susan E Bates; CW Berard; J M Boyett; N A Brophy; H J Broxterman; H S Chan; W S Dalton; M Dietel; A T Fojo; R D Gascoyne; D Head; Peter J Houghton; D K Srivastava; M Lehnert; CP Leith; Elisabeth Paietta; Z P Pavelic; R Weinstein
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Cancer research 1996;56(13):3010-20.
1996: Kevin M Barnes; B Dickstein; G B Cutler; Tito Fojo; Susan E Bates
Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.
Biochemistry 1996;35(15):4820-7.
1996: Susan E Bates; Wyndham H Wilson; Antonio Tito Fojo; M Alvarez; Zhirong Zhan; JT Regis; Robert W Robey; C Hose; Anne Monks; Y K Kang; B Chabner
Clinical reversal of multidrug resistance.
Stem cells (Dayton, Ohio) 1996;14(1):56-63.
1995: S Scala; B Dickstein; JT Regis; Z Szallasi; P M Blumberg; Susan E Bates
Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1581-7.
1995: K Wosikowski; J T Regis; Robert W Robey; M Alvarez; Jeroen Buters; J M Gudas; Susan E Bates
Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(11):1395-403.
1995: Wyndham H Wilson; Susan E Bates; Antonio Tito Fojo; G Bryant; Zhirong Zhan; JT Regis; Robert Wittes; Elaine S Jaffe; Seth M Steinberg; J Herdt
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1995-2004.
1995: Wyndham H Wilson; CA Jamis-Dow; G Bryant; FRANK BALIS; Raymond W Klecker; Susan E Bates; B A Chabner; Seth M Steinberg; David R Kohler; Robert Wittes
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1985-94.
1995: S Scala; Alfredo Budillon; Zhirong Zhan; Yoon S Cho-Chung; J Jefferson; M Tsokos; Susan E Bates
Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.
The Journal of clinical investigation 1995;96(2):1026-34.
1995: S Scala; T Saeki; A Lynch; D Salomon; Maria J Merino; Susan E Bates
Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1995;4(2):136-42.
1995: B M Dickstein; K Wosikowski; Susan E Bates
Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor.
Molecular and cellular endocrinology 1995;110(1-2):205-11.
1995: W H Wilson; Susan E Bates; A Fojo; B A Chabner
Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas.
Journal of cancer research and clinical oncology 1995;121 Suppl 3():R25-9.
1995: Susan E Bates; Beverly Meadows; Barry Goldspiel; A Denicoff; T B Le; E Tucker; Seth M Steinberg; L J Elwood
A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer.
Cancer chemotherapy and pharmacology 1995;35(6):457-63.
1995: Susan E Bates; A T Fojo; John N Weinstein; Timothy G Myers; M Alvarez; K D Pauli; B A Chabner
Molecular targets in the National Cancer Institute drug screen.
Journal of cancer research and clinical oncology 1995;121(9-10):495-500.
1994: Susan E Bates; JT Regis; Robert W Robey; Zhirong Zhan; S Scala; Beverly Meadows
Chemoresistance in the clinic: overview 1994.
Bulletin du cancer 1994;81 Suppl 2():55s-61s.
1994: J S Lee; KD Paull; M Alvarez; C Hose; Anne Monks; Michael R Grever; Antonio Tito Fojo; Susan E Bates
Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.
Molecular pharmacology 1994;46(4):627-38.
1994: B A Chabner; Susan E Bates; Antonio Tito Fojo; M Spolyar; W H Wilson
Drug resistance in adult lymphomas.
Seminars in hematology 1994;31(1):70-87.
1994: Susan E Bates; Zhirong Zhan; B Dickstein; J S Lee; S Scala; Antonio Tito Fojo; KD Paull; W Wilson
Reversal of multidrug resistance.
Journal of hematotherapy 1994;3(3):219-23.
1994: C E Herzog; Susan E Bates
Molecular diagnosis of multidrug resistance.
Cancer treatment and research 1994;73():129-47.
1994: Susan E Bates; Zhirong Zhan; B Dickstein; J S Lee; S Scala; Antonio Tito Fojo; KD Paull; W Wilson
Reversal of multidrug resistance.
Progress in clinical and biological research 1994;389():33-7.
1993: B Dickstein; E M Valverius; K Wosikowski; Miguel Saceda; J W Pearson; Mary Beth Martin; Susan E Bates
Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line.
Journal of cellular physiology 1993;157(1):110-8.
1993: Susan E Bates; J S Lee; B Dickstein; M Spolyar; Antonio Tito Fojo
Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Biochemistry 1993;32(35):9156-64.
1993: C E Herzog; M Tsokos; Susan E Bates; Antonio Tito Fojo
Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.
The Journal of biological chemistry 1993;268(4):2946-52.
1992: Susan E Bates; S J Currier; M Alvarez; Antonio Tito Fojo
Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.
Biochemistry 1992;31(28):6366-72.
1992: C E Herzog; Jane Trepel; Lyn A Mickley; Susan E Bates; Antonio Tito Fojo
Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Journal of the National Cancer Institute 1992;84(9):711-6.
1991: G M Lai; Y N Chen; Lyn A Mickley; Antonio Tito Fojo; Susan E Bates
P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
International journal of cancer. Journal international du cancer 1991;49(5):696-703.
1991: G M Lai; Jeffrey A Moscow; M G Alvarez; Antonio Tito Fojo; Susan E Bates
Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
International journal of cancer. Journal international du cancer 1991;49(5):688-95.
1991: Susan E Bates; C Y Shieh; Maria Tsokos
Expression of mdr-1/P-glycoprotein in human neuroblastoma.
The American journal of pathology 1991;139(2):305-15.
1991: Susan E Bates; C Y Shieh; Lyn A Mickley; H L Dichek; A Gazdar; Donald Lynn (Lynn) Loriaux; Antonio Tito Fojo
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
The Journal of clinical endocrinology and metabolism 1991;73(1):18-29.
1991: K Stromberg; M Duffy; C Fritsch; W R Hudgins; E S Sharp; L D Murphy; Marc Lippman; Susan E Bates
Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
Cancer detection and prevention 1991;15(4):277-83.
1990: L D Murphy; C E Herzog; J B Rudick; Antonio Tito Fojo; Susan E Bates
Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.
Biochemistry 1990;29(45):10351-6.
1990: D A Bronzert; Susan E Bates; J P Sheridan; R Lindsey; E M Valverius; M R Stampfer; Marc Lippman; Robert B Dickson
Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells.
Molecular endocrinology (Baltimore, Md.) 1990;4(7):981-9.
1990: Susan E Bates; E M Valverius; B W Ennis; D A Bronzert; J P Sheridan; M R Stampfer; J Mendelsohn; Marc Lippman; Robert B Dickson
Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells.
Endocrinology 1990;126(1):596-607.
1990: L D Murphy; E M Valverius; M Tsokos; Lyn A Mickley; Neal Rosen; Susan E Bates
Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines.
Cancer communications 1990;2(10):345-55.
1989: E M Valverius; D Walker-Jones; Susan E Bates; M R Stampfer; R Clark; F McCormick; Robert B Dickson; Marc Lippman
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
Cancer research 1989;49(22):6269-74.
1989: B W Ennis; E M Valverius; Susan E Bates; Marc Lippman; F Bellot; R Kris; J Schlessinger; H Masui; A Goldenberg; J Mendelsohn
Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 1989;3(11):1830-8.
1989: Lyn A Mickley; Susan E Bates; N D Richert; S Currier; S Tanaka; Francine M Foss; Neal Rosen; Antonio Tito Fojo
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
The Journal of biological chemistry 1989;264(30):18031-40.
1989: Susan E Bates; Lyn A Mickley; Y N Chen; N Richert; J Rudick; J L Biedler; Antonio Tito Fojo
Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.
Molecular and cellular biology 1989;9(10):4337-44.
1989: E M Valverius; Susan E Bates; M R Stampfer; R Clark; F McCormick; David S Salomon; Marc Lippman; Robert B Dickson
Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.
Molecular endocrinology (Baltimore, Md.) 1989;3(1):203-14.
1989: David S Salomon; W R Kidwell; N Kim; Fortunato Ciardiello; Susan E Bates; E Valverius; Marc Lippman; Robert B Dickson; M Stampfer
Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;113():57-69.
1989: Kevin J Cullen; D Yee; Susan E Bates; N Brunner; Robert Clarke; R E Dickson; K K Huff; Soonmyung Paik; Neal Rosen; E Valverius
Regulation of human breast cancer by secreted growth factors.
Acta oncologica (Stockholm, Sweden) 1989;28(6):835-9.
1988: Susan E Bates; Nancy E Davidson; E M Valverius; C E Freter; Robert B Dickson; J P Tam; J E Kudlow; Marc Lippman; David S Salomon
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
Molecular endocrinology (Baltimore, Md.) 1988;2(6):543-55.
1987: Robert B Dickson; A Kasid; K K Huff; Susan E Bates; Cornelius Knabbe; D Bronzert; Edward P Gelmann; Marc Lippman
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(3):837-41.